Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma

AIM: To investigate the influence of autologous cytokine-induced killer (CIK) cells on the phenotypes of CIK effector cells, peripheral T lymphocyte subsets and dendritic cell subsets in patients with primary hepatocellular carcinoma (HCC). METHODS: Peripheral blood mononuclear cells (PBMC) were col...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Shi, Ming, Zhang, Bing, Tang, Zi-Rong, Lei, Zhou-Yun, Wang, Hui-Fen, Feng, Yong-Yi, Fan, Zhen-Ping, Xu, Dong-Ping, Wang, Fu-Sheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2004
Témata:
Liver Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656350/
https://ncbi.nlm.nih.gov/pubmed/15069715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i8.1146
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky